Adocia (ADOC)

7.70
-0.08(-1.03%)
  • Volume:
    2,905
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    7.70 - 7.78
  • Type:Equity
  • Market:France
  • ISIN:FR0011184241

ADOC Overview

Prev. Close
7.78
Day's Range
7.7-7.78
Revenue
620K
Open
7.78
52 wk Range
7.65-11.9
EPS
-3.14
Volume
2,905
Market Cap
55.72M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
10,212
P/E Ratio
-
Beta
0.95
1-Year Change
-30.29%
Shares Outstanding
7,236,978
Next Earnings Date
Apr 19, 2022
What is your sentiment on Adocia?
or
Vote to see community's results!

Adocia Company Profile

Employees
127
Market
France

Adocia SA is a clinical-stage biotechnology company based in France. The Company specializes in the development of formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary technological platform BioChaperone is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. The Company’s clinical pipeline includes four novel insulin formulations for the treatment of diabetes: two formulations of insulin analog lispro (BioChaperone Lispro U100 and U200), a combination of basal insulin glargine and insulin lispro (BioChaperone Combo), and a combination of prandial insulin with amylin analog pramlintide: M1Pram. Its preclinical pipeline includes three products BioChaperone LisPram, BioChaperone Glargine GLP-1 and BioChaperone Glucagon GLP1.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.